schedule
Mixed results on scheduling
Migraine treatment and immediate release ibuprofen set to be downscheduled, but no change to status of another high profile medicine The migraine treatment eletriptan is to move to Schedule 3 …
Behind the counter
Upscheduling of Panadol Osteo confirmed by TGA, but change pushed back till 2020 The TGA’s Advisory Committee on Medicines Scheduling (ACMS) has confirmed its earlier decision to re-schedule modified release …
Paracetamol on the move
Modified release paracetamol upscheduled to S3, but GP groups express concern about the move Modified release paracetamol are set to be re-scheduled as S3 (Pharmacist Only) products according to the …
Sorting out the schedule
The new Appendix M category added to the Standard for Uniform Scheduling of Medicines and Poisons from February 2019 offers optimism that additional medicines might be considered for down‑scheduling from …
Getting the message out
Relaxed medicine advertising guidelines are set to boost downscheduling applications, industry believes Recent reforms to advertising regulations for Schedule 3 medicines are a “big win” for consumers, pharmacy and industry, …
What’s the best option?
Cost cutting on wages versus investing in companion selling to get results: do the simple math, it’s a no brainer, says Glenn Guilfoyle As I travel this big country of …
Change of schedule
Weekly-dose vitamin D products will be advertised from midway through the year following a decision that should enhance patient compliance Among the recommendations from the November meeting of the Advisory …
Still on hold
Codeine rescheduling decision deferred again as naproxen stays S2 The TGA has once again delayed announcing its final decision on the rescheduling fate of codeine-containing medicines. In its latest release …